Search Results
176 results
Your search is now limited to «Teva» expert search. 03/22/2019 17:45
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the launch of a generic version of EXJADE®1 (deferasirox) Tablets for Oral Suspension, 125 mg, 250 mg and 500 mg, in the U.S. Deferasirox Tablets for Oral Suspension are an iron chelator indicated for the treatment of chronic iron overload due to blood transfusions in patients two years of age and older.
More from
Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the launch of a generic.
More from Global Banking & Finance Review:
24/7 Wall Street 03/20/2019 08:55
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) was started as Hold with a $17 price target (versus a $16.91 close) at SunTrust Robinson Humphrey.
More from 24/7 Wall Street:
Novo Nordisk today announced that a settlement between Novo Nordisk and Teva Pharmaceuticals USA, Inc. (Teva) has been reached on the US patent litigation case for Victoza (liraglutide.
More from Pharmaceutical Business Review: 03/18/2019 17:50
Teva Pharmaceutical Industries Ltd. ( TEVA - Free Report) closed the most recent trading day at $16.64, moving +0.79% from the previous trading session.
More from
FiercePharmaManufacturing 03/06/2019 10:04
RELATED: Teva's stunning list of cuts targets 14K jobs, $3B in costs and plants around the globe According to the warning letter, the problems at the Actavis plant in Davie predate, Teva’s $40.5 billion purchase of Allergan’s generics business in 2016 ...
More from FiercePharmaManufacturing:
Motley Fool 03/06/2019 10:00
What happened Generic-drug giant Teva Pharmaceutical Industries (NYSE:TEVA) lost over 14% of its value during the month of February, according to data from S&P Global Market Intelligence.
More from Motley Fool:
Business Wire 03/01/2019 16:08
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the launch of an authorized generic of Flector®1 Patch, 1.3 %, in the U.S. Diclofenac Epolamine Topical Patch, 1.3%, a nonsteroidal anti-inflammatory drug (NSAID), is indicated for the topical treatment of acute pain due to minor strains, sprains and contusions.
More from Business Wire:
( ) Teva is a footwear label that specializes in outdoor exploration and its latest GC Pack recently dropped for the Spring/Summer 2019 season. It celebrates 100 years since the iconic Grand Canyon...
More from TREND HUNTER - The Latest Trends:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications